{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:19:59Z","timestamp":1793834399368,"version":"4.6.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>IMPORTANCE:<\/jats:title>\n                    <jats:p>The response of ICU patients to continuously infused ketamine when it is used for analgesia and\/or sedation remains poorly established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To describe continuous infusion (CI) ketamine use in critically ill patients, including indications, dose and duration, adverse effects, patient outcomes, time in goal pain\/sedation score range, exposure to analgesics\/sedatives, and delirium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN, SETTING, AND PARTICIPANTS:<\/jats:title>\n                    <jats:p>Multicenter, retrospective, observational study from twenty-five diverse institutions in the United States. Patients receiving CI ketamine between January 2014 and December 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN OUTCOMES AND MEASURES:<\/jats:title>\n                    <jats:p>Chart review evaluating institutional and patient demographics, ketamine indication, dose, administration, and adverse effects. Pain\/sedation scores, cumulative doses of sedatives and analgesics, and delirium screenings in the 24 hours prior to ketamine were compared with those at 0\u201324 hours and 25\u201348 hours after.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 390 patients were included (median age, 54.5 yr; interquartile range, 39\u201365 yr; 61% males). Primary ICU types were medical (35.3%), surgical (23.3%), and trauma (17.7%). Most common indications were analgesia\/sedation (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 357, 91.5%). Starting doses were 0.2\u2009mg\/kg\/hr (0.1\u20130.5\u2009mg\/kg\/hr) and continued for 1.6 days (0.6\u20132.9 d). Hemodynamics in the first 4 hours after ketamine were variable (hypertension 24.0%, hypotension 23.5%, tachycardia 19.5%, bradycardia 2.3%); other adverse effects were minimal. Compared with 24 hours prior, there was a significant increase in proportion of time spent within goal pain score after ketamine initiation (24\u2009hr prior: 68.9% [66.7\u201372.6%], 0\u201324 hr: 78.6% [74.3\u201382.5%], 25\u201348 hr: 80.3% [74.6\u201384.3%];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and time spent within goal sedation score (24\u2009hr prior: 57.1% [52.5\u201360.0%], 0\u201324 hr: 64.1% [60.7\u201367.2%], 25\u201348 hr: 68.9% [65.5\u201379.5%];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). There was also a significant reduction in IV morphine (mg) equivalents (24\u2009hr prior: 120 [25\u2013400], 0\u201324 hr: 118 [10\u2013363], 25\u201348 hr: 80 [5\u2013328];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.005), midazolam (mg) equivalents (24\u2009hr prior: 11 [4\u201367], 0\u201324 hr: 6 [0\u201368], 25\u201348 hr: 3 [0\u201357];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), propofol (mg) (24\u2009hr prior: 942 [223\u20134,018], 0\u201324 hr: 160 [0\u20132,776], 25\u201348 hr: 0 [0\u20131,859];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), and dexmedetomidine (\u00b5g) (24\u2009hr prior: 1,025 [276\u20131,925], 0\u201324 hr: 285 [0\u20131,283], 25\u201348 hr: 0 [0\u2013826];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). There was no difference in proportion of time spent positive for delirium (24\u2009hr prior: 43.0% [17.0\u201347.0%], 0\u201324 hr: 39.5% [27.0\u201343.8%], 25\u201348 hr: 0% [0\u201343.7%];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.233). Limitations to these data include lack of a comparator group, potential for confounders and selection bias, and varying pain and sedation practices that may have changed since completion of the study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS AND RELEVANCE:<\/jats:title>\n                    <jats:p>There is variability in the use of CI ketamine. Hemodynamic instability was the most common adverse effect. In the 48 hours after ketamine initiation compared with the 24 hours prior, proportion of time spent in goal pain\/sedation score range increased and exposure to other analgesics\/sedatives decreased.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cce.0000000000000633","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T12:01:47Z","timestamp":1644580907000},"page":"e0633","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Multicenter Retrospective Review of Ketamine Use in the ICU"],"prefix":"10.1097","volume":"4","author":[{"given":"Christine M.","family":"Groth","sequence":"first","affiliation":[{"name":"University of Rochester Medical Center, Departments of Pharmacy, Biostatistics and Computational Biology, and Emergency Medicine, Rochester, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Droege","sequence":"additional","affiliation":[{"name":"UC Health\u2014University of Cincinnati Medical Center, Department of Pharmacy Services, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Connor","sequence":"additional","affiliation":[{"name":"St. John Fisher College-Wegmans School of Pharmacy, Department of Pharmacy Practice and Administration, Rochester, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Kaukeinen","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Departments of Pharmacy, Biostatistics and Computational Biology, and Emergency Medicine, Rochester, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Acquisto","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Departments of Pharmacy, Biostatistics and Computational Biology, and Emergency Medicine, Rochester, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Ho J.","family":"Chui","sequence":"additional","affiliation":[{"name":"University of Maryland Medical Center, Department of Pharmacy, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaelia D.","family":"Cucci","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Akron General, Department of Pharmacy, Akron, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Dixit","sequence":"additional","affiliation":[{"name":"Ernest Mario School of PharmacyRutgers, The State University of New Jersey and Robert Wood Johnson University Hospital, New Brunswick, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Flannery","sequence":"additional","affiliation":[{"name":"University of Kentucky College of Pharmacy, Department of Pharmacy Practice and Science, Lexington, KY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle A.","family":"Gustafson","sequence":"additional","affiliation":[{"name":"Northeastern Ohio Medical University, Department of Pharmacy Practice, Rootstown, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina E.","family":"Glass","sequence":"additional","affiliation":[{"name":"Rutgers, New Jersey Medical School, Department of Surgery, Newark, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Horng","sequence":"additional","affiliation":[{"name":"University Hospital of New Jersey, Pharmaceutical Services, Newark, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh S.","family":"Heavner","sequence":"additional","affiliation":[{"name":"University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kinney","sequence":"additional","affiliation":[{"name":"Loma Linda University School of Pharmacy, Department of Pharmacy Practice, Loma Linda, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Kruer","sequence":"additional","affiliation":[{"name":"Indiana University Health, Adult Academic Health Center, Department of Pharmacy, Indianapolis, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Peppard","sequence":"additional","affiliation":[{"name":"Froedtert & the Medical College of Wisconsin, Department of Pharmacy and Department of Surgery, Division of Trauma and Acute Care Surgery, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeyaporn","family":"Sarangarm","sequence":"additional","affiliation":[{"name":"University of New Mexico Hospitals, Department of Pharmacy, Albuquerque, NM."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sikora","sequence":"additional","affiliation":[{"name":"University of Georgia College of Pharmacy, Department of Clinical and Administrative Pharmacy\/Augusta University Medical Center, Department of Pharmacy, Augusta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velliyur","family":"Viswesh","sequence":"additional","affiliation":[{"name":"Roseman University of Health Sciences, Department of Pharmacy Practice, Henderson, NV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Erstad","sequence":"additional","affiliation":[{"name":"University of Arizona College of Pharmacy, Department of Pharmacy Practice & Science, Tucson, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: An update (pharmacodynamics and molecular aspects, recent findings).","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: A review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy.","volume":"55","author":"Peltoniemi","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind.","volume":"10","author":"Li","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1213\/01.ANE.0000075837.67275.36","article-title":"The effects of small-dose ketamine on morphine consumption in surgical intensive care unit patients after major abdominal surgery.","volume":"97","author":"Guillou","year":"2003","journal-title":"Anesth Analg"},{"key":"R5-20240807","first-page":"175","article-title":"Use of ketamine in severe status asthmaticus in intensive care unit.","volume":"2","author":"Heshmati","year":"2003","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study.","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1097\/CCM.0000000000003204","article-title":"Adjunct ketamine use in the management of severe ethanol withdrawal.","volume":"46","author":"Pizon","year":"2018","journal-title":"Crit Care Med"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s40263-018-0569-6","article-title":"Ketamine for refractory status epilepticus: A systematic review.","volume":"32","author":"Rosati","year":"2018","journal-title":"CNS Drugs"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13181-018-0662-8","article-title":"Adjunctive use of ketamine for benzodiazepine-resistant severe alcohol withdrawal: A retrospective evaluation.","volume":"14","author":"Shah","year":"2018","journal-title":"J Med Toxicol"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/TA.0000000000002103","article-title":"Ketamine infusion for pain control in adult patients with multiple rib fractures: Results of a randomized control trial.","volume":"86","author":"Carver","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/TA.0000000000002479","article-title":"Ketamine infusion for pain control in elderly patients with multiple rib fractures: Results of a randomized controlled trial.","volume":"87","author":"Kugler","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcrc.2019.12.004","article-title":"Ketamine sedation in mechanically ventilated patients: A systematic review and meta-analysis.","volume":"56","author":"Manasco","year":"2020","journal-title":"J Crit Care"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU.","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"key":"R14-20240807","first-page":"69","article-title":"Guidelines for the clinical use of benzodiazepines: Pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology.","volume":"6","author":"Nelson","year":"1999","journal-title":"Can J Clin Pharmacol"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1345\/aph.1H421","article-title":"Opioid conversions in acute care.","volume":"41","author":"Patanwala","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R16-20240807","first-page":"36","article-title":"Ketamine infusions improve trauma and surgical pain.","volume":"2","author":"Mullins","year":"2018","journal-title":"J Pharmacol Med Chem"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0310057X9702500308","article-title":"Adverse cardiovascular effects of ketamine infusion in patients with catecholamine-dependent heart failure.","volume":"25","author":"Christ","year":"1997","journal-title":"Anaesth Intensive Care"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0885066612448732","article-title":"Cardiac arrest following ketamine administration for rapid sequence intubation.","volume":"28","author":"Dewhirst","year":"2013","journal-title":"J Intensive Care Med"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/phar.2065","article-title":"Ketamine infusion for adjunct sedation in mechanically ventilated adults.","volume":"38","author":"Groetzinger","year":"2018","journal-title":"Pharmacotherapy"},{"key":"R21-20240807","first-page":"456","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.","volume":"43","author":"Schwenk","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"e0157","DOI":"10.1097\/CCE.0000000000000157","article-title":"Adjuvant analgesic use in the critically ill: A systematic review and meta-analysis.","volume":"2","author":"Wheeler","year":"2020","journal-title":"Crit Care Explor"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0885066615618189","article-title":"Is admission to the intensive care unit associated with chronic opioid use? A 4-year follow-up of intensive care unit survivors.","volume":"32","author":"Yaffe","year":"2017","journal-title":"J Intensive Care Med"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamasurg.2019.0899","article-title":"New persistent opioid use after postoperative intensive care in US veterans.","volume":"154","author":"Karamchandani","year":"2019","journal-title":"JAMA Surg"},{"key":"R25-20240807","first-page":"170","article-title":"Incidence of chronic opioid use in previously opioid-na\u00efve patients receiving opioids for analgesia in the intensive care unit.","volume":"37","author":"Adil","year":"2020","journal-title":"Fed Pract"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M18-2864","article-title":"Patterns of opioid administration among opioid-naive inpatients and associations with postdischarge opioid use: A cohort study.","volume":"171","author":"Donohue","year":"2019","journal-title":"Ann Intern Med"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/phar.2042","article-title":"Impact of ketamine use on adjunctive analgesic and sedative medications in critically ill trauma patients.","volume":"37","author":"Pruskowski","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0885066617706907","article-title":"Impact of low-dose ketamine on the usage of continuous opioid infusion for the treatment of pain in adult mechanically ventilated patients in surgical intensive care units.","volume":"34","author":"Buchheit","year":"2019","journal-title":"J Intensive Care Med"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/phar.2223","article-title":"Continuous infusion ketamine for adjunctive analgosedation in mechanically ventilated, critically ill patients.","volume":"39","author":"Garber","year":"2019","journal-title":"Pharmacotherapy"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.accpm.2018.09.006","article-title":"Low doses of ketamine reduce delirium but not opiate consumption in mechanically ventilated and sedated ICU patients: A randomised double-blind control trial.","volume":"37","author":"Perbet","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0885066618767619","article-title":"Comparison of ketamine- versus nonketamine-based sedation on delirium and coma in the intensive care unit.","volume":"35","author":"Shurtleff","year":"2020","journal-title":"J Intensive Care Med"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1213\/ANE.0b013e3182662e30","article-title":"Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis.","volume":"115","author":"Dale","year":"2012","journal-title":"Anesth Analg"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(17)31467-8","article-title":"Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: An international, multicentre, double-blind, randomised clinical trial.","volume":"390","author":"Avidan","year":"2017","journal-title":"Lancet"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"e0544","DOI":"10.1097\/CCE.0000000000000544","article-title":"Exploring ketamine analgosedation use and its effect on incident delirium in critically ill adults.","volume":"3","author":"Wu","year":"2021","journal-title":"Crit Care Explor"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T10:32:46Z","timestamp":1723026766000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000633","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}